Pharmaceutical Innovations recalls
Pharmaceutical Innovations has 6 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 26 Aug 2020. The most frequent reason is potency & assay.
Total recalls6since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 26 Aug 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 100%Class III 0 0%
Why pharmaceutical innovations is recalled
Product types
By year
All pharmaceutical innovations recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Ultra/Phonic Focus BP Conforming Gel Pads recalled | Pharmaceutical Innovations | Packaging Defects | Nationwide |
| Device | CLASS II | Alpha Conducting solution product codes:3310-15 ACS recalled | Pharmaceutical Innovations | Potency & Assay | Nationwide |
| Device | CLASS II | ElectroMist product codes recalled by Pharmaceutical Innovations | Pharmaceutical Innovations | Potency & Assay | Nationwide |
| Device | CLASS II | ElectroMist product codes recalled by Pharmaceutical Innovations | Pharmaceutical Innovations | Potency & Assay | Nationwide |
| Device | CLASS II | Alpha Conducting solution product codes: 3310-25 ASCR recalled | Pharmaceutical Innovations | Potency & Assay | Nationwide |
| Device | CLASS II | ElectroMist product codes recalled by Pharmaceutical Innovations | Pharmaceutical Innovations | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.